- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05343390
Package of Resources for Assisted Contact Tracing: Implementation, Costs, and Effectiveness (PRACTICE)
Enhancing HIV-assisted Contact Tracing in Malawi Through Blended Learning: an Implementation Science Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Voluntary assisted contact tracing (ACT) is an evidence-based approach that efficiently identifies persons in need of HIV treatment and prevention. Malawi, like many countries in sub-Saharan Africa, has adopted ACT policies to support its "95-95-95" targets for HIV testing, treatment, and viral suppression.
However, Malawi's ACT implementation has been poor due to deficits in health worker capacity and clinical coordination. Through preliminary work, our team has 1) developed a set of implementation strategies (theory-based health worker training and continuous quality improvement processes) that address these barriers; 2) packaged these strategies into a blended learning platform that combines digital and face-to-face modalities; and 3) field-tested the package in Malawi with promising preliminary results. In this proposal, the package will be rigorously evaluated in Malawi for implementation, service uptake, and cost-effectiveness outcomes.
Through a two-arm pragmatic cluster randomized implementation trial, the proposed research will address these gaps through three specific aims. Twenty Malawian facilities in two districts will be randomized to receive the blended learning implementation package (enhanced) versus standard implementation package (standard). In the first aim, ACT implementation outcomes will be compared between the enhanced and standard arms. Health worker fidelity to ACT procedures will be assessed through audio-recorded ACT encounters. In the second aim, HIV service uptake outcomes will be compared between the enhanced and standard arms. In the third aim, cost and cost-effectiveness outcomes will be examined.
The findings will offer important insights and innovations into how to bridge the gap between ACT research and practice, a critical step towards achieving the 95-95-95 targets.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Balaka, Malawi
- Balaka District Hospital
-
Balaka, Malawi
- Balaka OPD Health Centre
-
Balaka, Malawi
- Chiendausiku Health Centre
-
Balaka, Malawi
- Kalembo Health Centre
-
Balaka, Malawi
- Kankao Health Centre
-
Balaka, Malawi
- Kwitanda Health Centre
-
Balaka, Malawi
- Mbera health Centre
-
Balaka, Malawi
- Namanolo Health Centre
-
Balaka, Malawi
- Namdumbo Health Centre
-
Balaka, Malawi
- Phalula Health Centre
-
Balaka, Malawi
- Phimbi Health Centre
-
Balaka, Malawi
- Ulongwe Health Centre
-
Balaka, Malawi
- Utale Health Centres
-
Machinga, Malawi
- Machinga District Hospital
-
Machinga, Malawi
- Chamba Dispensary
-
Machinga, Malawi
- Chikweo Health Centre
-
Machinga, Malawi
- Gawanani Health Centre
-
Machinga, Malawi
- Kawinga Dispensary
-
Machinga, Malawi
- Mahinga Health Centre
-
Machinga, Malawi
- Mangamba Health Centre
-
Machinga, Malawi
- Mbonechela Dispensary
-
Machinga, Malawi
- Mkwepere Health Centre
-
Machinga, Malawi
- Mpiri Health Centre
-
Machinga, Malawi
- Mposa Health Centre
-
Machinga, Malawi
- Namandanje Health Centre
-
Machinga, Malawi
- Namanja Health Centre
-
Machinga, Malawi
- Nayinunje Health Centre
-
Machinga, Malawi
- Nayuchi Health Centre
-
Machinga, Malawi
- Ngokwe Health Centre
-
Machinga, Malawi
- Nsanama Health Centre
-
Machinga, Malawi
- Ntaja Health Centre
-
Machinga, Malawi
- Nthorowa Health Centre
-
Machinga, Malawi
- Nyambi Health Centre
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Health worker inclusion criteria:
- 18 years of age or older
- working full-time at one of the health facilities included in the study
- staff in Malawi's Assisted Contact Tracing program.
Health worker exclusion criteria:
- conditions that would compromise ability of participant to provide informed consent, undergo study procedures safely, or prevent proper conduct of study
Patient (index or contact) inclusion criteria:
->=15 years
-potential index, contact, or parent or guardian of a potential index or contact
Patient (index or contact) exclusion criteria:
- conditions that would compromise ability of individual to provide informed consent, undergo study procedures safely, or prevent proper conduct of study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Enhanced implementation strategy
digitally guided training and continuous quality improvement
|
Individual training with teaching and modeling (tablet-guided, ~8 hours) Small group training with practice and feedback (tablet-guided, ~16 hours) Ongoing continuous quality improvement sessions (tablet-guided, ~2 hours/month)
Individual training with teaching (facilitator-guided, ~2 hours) Small group practice (facilitator-guided, ~1 hour) Ongoing clinic support (facilitator-guided, ~30 minutes/month)
|
|
Active Comparator: Standard implementation strategy
standard training and clinical support
|
Individual training with teaching (facilitator-guided, ~2 hours) Small group practice (facilitator-guided, ~1 hour) Ongoing clinic support (facilitator-guided, ~30 minutes/month)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Index Client Fidelity Assessment
Time Frame: 1 year after training
|
Health care workers will be observed counseling actual index clients.
The scores on the 15-item index client fidelity assessment will be compared between arms (range 0-100% with higher scores being better)
|
1 year after training
|
|
Contact Client Fidelity Assessment
Time Frame: 1 year after training
|
Health care workers will be observed counseling actual contact clients.
The scores on the 15-item contact client fidelity assessment will be compared between arms (range 0-100% with higher scores being better)
|
1 year after training
|
|
Index Clients Who Participate in Assisted Contact Tracing
Time Frame: 1 year after training
|
The total number of index clients who participate in assisted contact tracing relative to the number of total potential index clients measured per facility per calendar quarter (3-month period).
Each cluster contributes 4 quarters of data.
|
1 year after training
|
|
Contact Clients Elicited
Time Frame: 1 year after training
|
The number of contact clients listed by participating index clients relative to the number of total potential index clients measured per facility per calendar quarter (3-month period).
Each cluster contributes 4 quarters of data.
|
1 year after training
|
|
HIV Self-test Kits Distributed
Time Frame: 1 year after training
|
The number of HIV self-test kits distributed relative to the number of total potential index clients measured per facility per calendar quarter (3-month period).
Each cluster contributes 4 quarters of data.
|
1 year after training
|
|
Contact Clients Tested
Time Frame: 1 year after training
|
The number of contact clients tested relative to the number of total potential index clients measured per facility per calendar quarter (3-month period).
Each cluster contributes 4 quarters of data.
|
1 year after training
|
|
Contact Clients Living With HIV Identified
Time Frame: 1 year after training
|
The number of contact clients living with HIV identified relative to the number of total potential index clients measured per facility per calendar quarter (3-month period).
Each cluster contributes 4 quarters of data.
|
1 year after training
|
|
Incremental Cost Per Contact Tested
Time Frame: 1 year after training
|
Incremental cost per contact tested for HIV = Total additional cost in enhanced arm ($127,319) / total number of additional individual tested for HIV in the enhanced arm (1119).
The outcome is an incremental cost effectiveness ratio.
Because no additional cost was incurred in the Standard arm, the value was reported as 0.
|
1 year after training
|
|
Incremental Cost Per Person Living With HIV Diagnosed
Time Frame: 1 year after training
|
Incremental cost per contact tested for HIV = Total additional cost in enhanced arm ($127,319) / total number of additional individual diagnosed with HIV in the enhanced arm (64).
The outcome is an incremental cost effectiveness ratio.
Because no additional cost was incurred in the Standard arm, the value is reported as 0.
|
1 year after training
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Nora E Rosenberg, PhD, University of North Carolina, Chapel Hill
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Blood-Borne Infections
- Urogenital Diseases
- Genital Diseases
- Immune System Diseases
- Infections
- RNA Virus Infections
- Virus Diseases
- Communicable Diseases
- Sexually Transmitted Diseases, Viral
- Sexually Transmitted Diseases
- Lentivirus Infections
- Retroviridae Infections
- Immunologic Deficiency Syndromes
- Slow Virus Diseases
- HIV Infections
- Acquired Immunodeficiency Syndrome
Other Study ID Numbers
- 20-1810
- R01MH124526 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Human Immunodeficiency Virus
-
Merck Sharp & Dohme LLCWithdrawnHIV-1 | Immunodeficiency Virus Type 1, Human | Human Immunodeficiency Virus Type 1 | Human Immunodeficiency Virus 1
-
MacroGenicsNational Institute of Allergy and Infectious Diseases (NIAID); National Institutes... and other collaboratorsCompletedHuman Immunodeficiency Virus I Infection | Immunodeficiency Virus Type 1, Human | Human Immunodeficiency Virus Type 1United States
-
National Institute of Allergy and Infectious Diseases...CompletedHuman Immunodeficiency Virus (HIV) | Human Immunodeficiency Virus PreventionUnited States
-
EMD SeronoCompletedHuman Immunodeficiency Virus Infections | Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome (HARS)
-
Oswaldo Cruz FoundationRecruitingContact With or Exposure to Human Immunodeficiency VirusBrazil
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency Virus | Infections, Human Immunodeficiency Virus and HerpesviridaeUnited States
-
EMD SeronoCompletedHuman Immunodeficiency Virus Infections | Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome (HARS)
-
bioLytical LaboratoriesCompletedHuman Immunodeficiency Virus I Infection | Human Immunodeficiency Virus II InfectionCanada
-
bioLytical LaboratoriesCompletedHuman Immunodeficiency Virus I Infection | Human Immunodeficiency Virus II InfectionUnited States
-
Immuno Cure Holding (HK) LimitedThe University of Hong Kong; Immuno Cure 1 LimitedRecruitingHuman Immunodeficiency Virus | Human Immunodeficiency Virus I InfectionHong Kong
Clinical Trials on Enhanced implementation package
-
University of North Carolina, Chapel HillNational Institute of Mental Health (NIMH); Kamuzu University of Health Sciences and other collaboratorsCompleted
-
Medical University of South CarolinaNational Institutes of Health (NIH)Not yet recruitingPrevention | Maltreatment | Parenting Intervention
-
University of WashingtonNational Institute of Mental Health (NIMH); National Institutes of Health (NIH)Enrolling by invitation
-
Geisinger ClinicNational Heart, Lung, and Blood Institute (NHLBI)Enrolling by invitationFamilial HypercholesterolemiaUnited States
-
University of North Carolina, Chapel HillNational Center for Complementary and Integrative Health (NCCIH)Enrolling by invitation
-
Iowa State UniversityKansas State University; Louisiana State University Health Sciences Center... and other collaboratorsCompletedHealth Promotion | Overweight and Obesity | Sedentary Behavior | Diet, Healthy | Healthy LifestyleUnited States
-
Centers for Disease Control and PreventionUnited States President's Emergency Plan for AIDS ReliefCompleted
-
University of Wisconsin, MadisonNational Institute on Aging (NIA)RecruitingSurgery | Implementation Science | Geriatric Assessment | Health Services ResearchUnited States
-
VA Office of Research and DevelopmentCompletedTerminal Conditions, End of LifeUnited States
-
University of MiamiNational Institute of Mental Health (NIMH); Massachusetts General Hospital; University...RecruitingDepression | HIV | AIDS | Adherence, TreatmentUnited States, South Africa